These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1963796)

  • 21. Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway.
    Zeng H; Liu X; Dou S; Xu W; Li N; Liu X; Zhang W; Hu Z; Liu R
    J Pharm Pharmacol; 2009 Dec; 61(12):1699-707. PubMed ID: 19958594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research on the effect of a new anti-inflammatory thiazole compound, 2-(4-chlorophenyl)-thiazol-4-ylacetate of ethyl, on a model of experimental inflammation with pathogenesis involving the labilization of lysosome membranes].
    Gafiţanu E; Pavelescu M; Sunel V; Dàneţ R
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(3):471-4. PubMed ID: 6985563
    [No Abstract]   [Full Text] [Related]  

  • 23. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
    Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
    J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-lipoxygenase inhibitory activity of zileuton.
    Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
    J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
    Fogh K; Iversen L; Herlin T; Kragballe K
    Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
    Rao TS; Yu SS; Djuric SW; Isakson PC
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
    Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-(2-hydroxy-4-methylphenyl)aminothiazole hydrochloride as a dual inhibitor of cyclooxygenase/lipoxygenase and a free radical scavenger. 1st communication: in vitro studies.
    Bonne C; Muller A; Latour E; Tissie G; Emerit I; Modat G; Dornand J; Roch M; Giroud JP; Griswold DE
    Arzneimittelforschung; 1989 Oct; 39(10):1242-5. PubMed ID: 2514692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory response of human tendon fibroblasts to cyclic mechanical stretching.
    Li Z; Yang G; Khan M; Stone D; Woo SL; Wang JH
    Am J Sports Med; 2004 Mar; 32(2):435-40. PubMed ID: 14977670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolyl and benzothiazolyl Schiff bases as novel possible lipoxygenase inhibitors and anti inflammatory agents. Synthesis and biological evaluation.
    Hadjipavlou-Litina DJ; Geronikaki AA
    Drug Des Discov; 1998 May; 15(3):199-206. PubMed ID: 9689502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effects of LY221068 and LY269415.
    Panetta JA; Benslay DN; Shadle JK; Towner RD; Ho PP
    Agents Actions; 1991 Sep; 34(1-2):100-2. PubMed ID: 1793009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and anti-inflammatory evaluation of some new acyl-hydrazones bearing 2-aryl-thiazole.
    Moldovan CM; Oniga O; Pârvu A; Tiperciuc B; Verite P; Pîrnău A; Crişan O; Bojiţă M; Pop R
    Eur J Med Chem; 2011 Feb; 46(2):526-34. PubMed ID: 21163557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-(2-hydroxy-4-methylphenyl)aminothiazole hydrochloride as a dual inhibitor of cyclooxygenase/lipoxygenase and a free radical scavenger. 2nd communication: anti-inflammatory activity.
    Bonne C; Latour E; Muller A; de Kozak Y; Faure JP; Malet F; Colin J; Tissot M; Giroud JP; Maghni K
    Arzneimittelforschung; 1989 Oct; 39(10):1246-50. PubMed ID: 2514693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
    Sinha S; Doble M; Manju SL
    Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [2-Aryl-pyrrolo[2,1-b]benzothiazoles as a selective or dual inhibitors of cyclo-oxygenases and 5-lipoxygenases. 21. Non-steroidal anti-inflammatory agents].
    Dannhardt G; Kreher M; Nowe U; Schmitt S
    Pharmazie; 1997 Jun; 52(6):428-36. PubMed ID: 9324689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
    Goodman LA; Torres BT; Reynolds LR; Budsberg SC
    Am J Vet Res; 2010 Sep; 71(9):1067-73. PubMed ID: 20807147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of some newer non-steroidal anti-inflammatory indan-1-acids in various biological systems.
    Mukhopadhyay A; Lahiri SC
    Indian J Exp Biol; 1992 Jul; 30(7):583-6. PubMed ID: 1459631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo.
    Bauer J; Koeberle A; Dehm F; Pollastro F; Appendino G; Northoff H; Rossi A; Sautebin L; Werz O
    Biochem Pharmacol; 2011 Jan; 81(2):259-68. PubMed ID: 20933508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of (2-fluoro-benzyl)-(2-methyl-2-phenethyl-2H-chromen-6-yl)-amine (KRH-102140) as an orally active 5-lipoxygenase inhibitor with activity in murine inflammation models.
    Cho YS; Song JS; Huh JY; Kim CH; Gong YD; Cheon HG
    Pharmacology; 2011; 87(1-2):49-55. PubMed ID: 21212714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.